Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CIGNA CORPORATION

(CI)
  Report
Delayed Quote. Delayed Nyse - 01/24 03:56:03 pm
236 USD   -0.11%
06:24aCIGNA : Regulation FD Disclosure - Form 8-K
PU
06:17aCIGNA CORP : Regulation FD Disclosure (form 8-K)
AQ
01/20CIGNA CORPORATION : No turn-around in sight
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Seaport Global Starts Cigna at Buy with $270 Price Target On "Stronger" Healthcare Business

11/17/2021 | 09:07am EST


ę MT Newswires 2021
All news about CIGNA CORPORATION
06:24aCIGNA : Regulation FD Disclosure - Form 8-K
PU
06:17aCIGNA CORP : Regulation FD Disclosure (form 8-K)
AQ
01/19Oppenheimer Adjusts Cigna's Price Target to $300 From $285, Maintains Outperform Rating
MT
01/06INSIDER SELL : Cigna
MT
01/06Wells Fargo Upgrades Cigna to Overweight From Equalweight
MT
01/05Truist Adjusts Price Target on Cigna to $275 From $270, Maintains Buy Rating
MT
01/04Molina Healthcare Acquires Cigna's Texas Medicaid Contracts
MT
2021Cigna Expects to Reiterate Earnings Guidance at Upcoming Investor Meetings
MT
2021Cigna Reaffirms Earnings Forecast for FY21, FY22
MT
2021CIGNA : Regulation FD Disclosure - Form 8-K
PU
More news
Analyst Recommendations on CIGNA CORPORATION
More recommendations
Financials (USD)
Sales 2021 172 B - -
Net income 2021 5 421 M - -
Net Debt 2021 27 740 M - -
P/E ratio 2021 14,8x
Yield 2021 1,69%
Capitalization 78 300 M 78 300 M -
EV / Sales 2021 0,61x
EV / Sales 2022 0,57x
Nbr of Employees 72 963
Free-Float -
Chart CIGNA CORPORATION
Duration : Period :
Cigna Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 236,25 $
Average target price 259,72 $
Spread / Average Target 9,93%
EPS Revisions
Managers and Directors
David Michael Cordani Chairman, President & Chief Executive Officer
Brian C. Evanko Chief Financial Officer & Executive Vice President
Noelle K. Eder Global Chief Information Officer & Executive VP
Paul Sanford Executive Vice President-Operations
John M. Murabito Chief Administrative Officer
Sector and Competitors
1st jan.Capi. (M$)
CIGNA CORPORATION2.88%78 300
UNITEDHEALTH GROUP-8.16%434 354
ANTHEM, INC.-4.74%107 173
HUMANA INC.-19.10%48 232
CENTENE CORPORATION-6.38%45 011
MOLINA HEALTHCARE, INC.-12.58%16 240